filings.toolsItem 6. Selected Financial Data
4K characters. Original on sec.gov ·
Item 6. Selected Financial Data
The consolidated financial data below includes all business combinations as of the date of acquisition that occurred during these periods. The following selected consolidated financial data should be read in conjunction with the consolidated financial statements and related notes and “Item 7: Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
| (in millions, except per common share amounts) | 2014 | 2013 (1) | 2012 | 2011 | 2010 | ||||||||||||||
| Earnings Data: | |||||||||||||||||||
| Revenue | $ | 91,084 | $ | 101,093 | $ | 107,552 | $ | 102,644 | $ | 98,503 | |||||||||
| Earnings from continuing operations | $ | 1,163 | $ | 335 | $ | 1,070 | $ | 966 | $ | 587 | |||||||||
| Earnings/(loss) from discontinued operations (2) | 3 | (1 | ) | (1 | ) | (7 | ) | 55 | |||||||||||
| Net earnings | $ | 1,166 | $ | 334 | $ | 1,069 | $ | 959 | $ | 642 | |||||||||
| Basic earnings/(loss) per common share: | |||||||||||||||||||
| Continuing operations | $ | 3.41 | $ | 0.98 | $ | 3.10 | $ | 2.77 | $ | 1.64 | |||||||||
| Discontinued operations (2) | 0.01 | — | — | (0.02 | ) | 0.15 | |||||||||||||
| Net basic earnings per common share | $ | 3.42 | $ | 0.98 | $ | 3.10 | $ | 2.75 | $ | 1.79 | |||||||||
| Diluted earnings/(loss) per common share: | |||||||||||||||||||
| Continuing operations | $ | 3.37 | $ | 0.97 | $ | 3.06 | $ | 2.74 | $ | 1.62 | |||||||||
| Discontinued operations (2) | 0.01 | — | — | (0.02 | ) | 0.15 | |||||||||||||
| Net diluted earnings per common share | $ | 3.38 | $ | 0.97 | $ | 3.06 | $ | 2.72 | $ | 1.77 | |||||||||
| Cash dividends declared per common share | $ | 1.2500 | $ | 1.0900 | $ | 0.8825 | $ | 0.8000 | $ | 0.7200 | |||||||||
| Balance Sheet Data: | |||||||||||||||||||
| Total assets | $ | 26,033 | $ | 25,819 | $ | 24,260 | $ | 22,846 | $ | 19,990 | |||||||||
| Long-term obligations, less current portion | 3,171 | 3,686 | 2,418 | 2,175 | 1,896 | ||||||||||||||
| Shareholders’ equity | 6,401 | 5,975 | 6,244 | 5,849 | 5,276 |
| (1) | During the fourth quarter of fiscal 2013, we recognized a non-cash goodwill impairment charge of $829 million ($799 million, net of tax) related to our Nuclear Pharmacy Services division. |
| (2) | On August 31, 2009, we separated the clinical and medical products businesses from our other businesses through a pro rata distribution to shareholders of 81 percent of the then outstanding common stock of CareFusion and met the criteria for classification of these businesses as discontinued operations. |
| Table of Contents | Cardinal Health, Inc. and Subsidiaries | |
| Financial Review |
Previous: Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities · Next: Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Sponsor Sponsor this sector. One slot per industry, shown on every filing in it. Details